Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptorepositive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study - Decker, T.; Fasching, Peter; Nusch, A.; Hartkopf, A.; Heinrich, B. J.; Kurbacher, C. M.; Fuchs, R.; Tesch, H.; Krabisch, P.; Huober, J.; Kuemmel, S.; Brucker, S. Y.; et al. (ANNALS OF ONCOLOGY, 2021)
CRIS-Team WoS Importer:2021-10-15